Aurobindo calls off $900 million Sandoz buy in US
Nearly a year and a half year after Hyderabad-based pharma major Aurobindo Pharma announced its big ticket, $900 million deal to acquire Sandoz Inc’s US generic oral solids and dermatology…
Continue Reading Aurobindo calls off $900 million Sandoz buy in US